1
|
Mandolfo NR, Berger AM, Struwe L, Hanna KM, Goldner W, Klute K, Langenfeld S, Hammer M. Glycemic Variability Within 1 Year Following Surgery for Stage II-III Colon Cancer. Biol Res Nurs 2022; 24:64-74. [PMID: 34610762 PMCID: PMC9248290 DOI: 10.1177/10998004211035184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
OBJECTIVE To examine glycemic variability within 1 month and 1 year following surgery among adult patients, with and without Type 2 Diabetes (T2D), treated for stage II-III colon cancer. METHOD A retrospective analysis of electronic health record data was conducted. Glycemic variability (i.e., standard deviation [SD] and coefficient of variation [CV] of > 2 blood glucose measures) was assessed within 1 month and within 1 year following colon surgery. Chi-square (χ2), Fisher's exact, and Mann-Whitney U tests were used for the analyses. RESULTS Among the sample of 165 patients with stage II-III colon cancer, those with T2D had higher glycemic variability compared to patients without T2D (p < .001), with values within 1 month following surgery (SD = 44.69 mg/dL, CV = 27.4%) vs (SD = 20.55 mg/dL, CV = 17.53%); and within 1 year following surgery (SD = 45.04 mg/dL, CV = 29.04%) vs (SD = 21.36 mg/dL, CV = 18.6%). Associations were found between lower body mass index and higher glycemic variability (i.e., SD [r = -.413, p < .05] and CV [r = -.481, p < .01]) within 1 month following surgery in patients with T2D. Higher preoperative glucose was associated with higher glycemic variability (i.e., SD r = .448, p < .01) within 1 year in patients with T2D. Demographic and clinical characteristics were weakly associated with glycemic variability in patients without T2D. CONCLUSIONS Patients with stage II-III colon cancer with T2D experienced higher glycemic variability within 1 month and within 1 year following surgery compared to those without T2D. Associations between glycemic variability and demographic and clinical characteristics differed by T2D status. Further research in prospective studies is warranted.
Collapse
Affiliation(s)
- Natalie Rasmussen Mandolfo
- College of Nursing, Nebraska Medical
Center, University of Nebraska Medical Center, Omaha, NE, USA,Natalie Rasmussen Mandolfo, PhD, APRN-NP,
AOCN, University of Nebraska Medical Center, 985330 Nebraska Medical Center,
Omaha, NE 68198, USA. Emails: ;
| | - Ann M. Berger
- College of Nursing, Nebraska Medical
Center, University of Nebraska Medical Center, Omaha, NE, USA
| | - Leeza Struwe
- College of Nursing, Nebraska Medical
Center, University of Nebraska Medical Center, Omaha, NE, USA
| | - Kathleen M. Hanna
- College of Nursing, Nebraska Medical
Center, University of Nebraska Medical Center, Omaha, NE, USA
| | - Whitney Goldner
- Department of Internal Medicine,
Section of Diabetes, Nebraska Medical Center, University of Nebraska Medical Center,
Omaha, NE, USA
| | - Kelsey Klute
- Department of Internal Medicine,
Division of Oncology & Hematology, Nebraska Medical Center, University of
Nebraska Medical Center, Omaha, NE, USA
| | - Sean Langenfeld
- Department of Surgery, Nebraska Medical
Center, University of Nebraska Medical Center, Omaha, NE, USA
| | | |
Collapse
|